Reddy Rajiv, Prasad Rupa, Rejai Sepehr, Halter Kenneth, Chen Jeffrey
From the Department of Anesthesia, Pain Medicine, University of California San Diego Health Center, La Jolla, California.
Department of Pain Medicine, Sutter East Bay Medical Group, Berkeley, California.
A A Pract. 2019 Dec 1;13(11):409-412. doi: 10.1213/XAA.0000000000001078.
Transverse myelitis (TM) is a rare neurologic disorder of acute inflammation resulting in spinal cord injury. Chronic pain in TM is a significant detriment to quality of life. Spinal cord stimulation (SCS) is an emerging treatment that has shown significant efficacy in neuropathic pain. We present a 37-year-old man with a history of idiopathic thoracic TM and refractory chronic neuropathic pain who underwent an SCS trial. He reported 70% improvement during the trial and was subsequently implanted with an SCS. He continues to experience significant pain relief and functional improvement (>80%) with conventional paresthesia programming at the 9-month follow-up.
横贯性脊髓炎（TM）是一种罕见的急性炎症性神经系统疾病，可导致脊髓损伤。TM中的慢性疼痛对生活质量有重大损害。脊髓刺激（SCS）是一种新兴的治疗方法，已显示出对神经性疼痛有显著疗效。我们报告了一名37岁男性，有特发性胸段TM病史和难治性慢性神经性疼痛，他接受了SCS试验。他在试验期间报告疼痛改善了70%，随后植入了SCS。在9个月的随访中，通过传统的感觉异常编程，他继续经历显著的疼痛缓解和功能改善（>80%）。
